Publication of Clinical Results in ACS Sensors
Findings in clinical studies indicate that the combination of Raman Spectroscopy with multivariate data analysis, is the best fit for at-home non-invasive monitoring of glucose levels in people with diabetes. At RSP, we are not only demonstrating that Raman can measure glucose accurately and pain-free, but also that it provides stable calibration for a long […]
A Strong Partnership Announcement – Trumpf Photonics
RSP Systems is proud to announce that we have entered the new year with a strong partnership with Trumpf Photonics. Since the introduction of CGM more than 20 years ago, people with diabetes have searched for a more convenient solution to manage their disease. At RSP Systems, we are developing the world’s first non-invasive glucose […]
RSP Secures EUR 5 million Series C, tranche 2 funding to advance its TGM technology
RSP raises EUR 5 million in its second closing of Series C and completes a Series C fundraise of EUR 11.5 million accelerating its development plans toward non-invasive glucose measurement. RSP has now raised more than EUR 32.5 million…
RSP Systems Joins The Soonicorn Club of Denmark
We are pleased to announce that RSP Systems A/S has been selected to be a part of the Soonicorn club of Denmark – an elite group of the most promising Denmark startups that have reached significant valuation milestones over the previous few years. RSP Systems was recognised as a Top Tech Minicorn in Denmark by […]
